ProMIS Neurosciences Inc. Common Shares (ON)
Symbol: PMN (NASDAQ)
0.40
▼ (-1.00%) -0.004
Company Description:
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
Key Stats
- Today's Open: $0.4
- Today's High: $0.424
- Today's Low: $0.395
- Today's Volume: 542.00K
- Yesterday Close: $0.399
- Yesterday High: $0.4199
- Yesterday Low: $0.385
- Yesterday Volume: 589.15K
- Last Min Volume: 551
- Last Min High: $0.395
- Last Min Low: $0.395
- Last Min VWAP: $0.395
Company Profile
- Name: ProMIS Neurosciences Inc. Common Shares (ON)
- Website: https://www.promisneurosciences.com
- Listed Date: 2005-09-30
- Location: TORONTO, A6
- Market Status: Active
- CIK Number: 0001374339
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $21.18M
- Round Lot: 100
- Outstanding Shares: 51.81M
- Asset Type: CS
RECENT FILINGS FOR PMN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-24 | 4 | View |
| 2025-09-24 | 4 | View |
| 2025-09-24 | 4 | View |
| 2025-09-24 | 4 | View |
| 2025-09-24 | 4 | View |
| 2025-09-23 | PRE 14A | View |
| 2025-09-10 | EFFECT | View |
| 2025-09-08 | 4 | View |
| 2025-09-04 | S-3 | View |
| 2025-09-03 | 8-K | View |
| 2025-08-22 | EFFECT | View |
| 2025-08-20 | CORRESP | View |
| 2025-08-20 | UPLOAD | View |
| 2025-08-19 | 8-K | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | 3 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | 4/A | View |
| 2025-08-14 | 4/A | View |
| 2025-08-14 | 4 | View |
Latest News on PMN